News
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROLâ„¢ Trials Jan. 13, 2025 8:00 AM ET Jupiter Neurosciences, Inc. (JUNS) ...
Model of how TBK1/IKKε prevent cell death: by inhibiting premature activation of RIPK1 and NLRP3 in death-inducing pathways. Credit: Science Advances (2025). DOI: 10.1126/sciadv.adq1047 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback